Open AccessS0809 Is There a Benefit of Immunomodulator and Anti-TNF Combination Therapy Over Monotherapy in the Real World, Long-Term Management of IBD? Assessing Multiyear Treatment Persistence and Mucosal Healing
Author(s) -
Filippos Koutroumpakis,
Maaz Ahsan,
Claudia Ramos Rivers,
Zaid Alkaissy,
Siobhan Proksell,
Elyse Johnston,
Marc Schwartz,
Jeffrey Dueker,
Jana Al Hashash,
Arthur Barrie,
Gong Tang,
Dmitriy Babichenko,
Michael A. Dunn,
David G. Binion
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705284.34778.15
Subject(s) - medicine , thiopurine methyltransferase , infliximab , adalimumab , gastroenterology , ulcerative colitis , inflammatory bowel disease , faecal calprotectin , hypoalbuminemia , combination therapy , crohn's disease , cohort , surgery , disease , calprotectin